Skip to content
Clinical Trials – home
Universitaet Muenster
Sponsor

Universitaet Muenster

Germany Schlossplatz 2, Schlossbezirk, 48149 Munster, Germany

About the sponsor

Research activity includes diffuse large B-cell lymphoma, primary mediastinal large B-cell lymphoma, follicular lymphoma, and high-grade B-cell lymphoma, with a strong focus on advanced treatment strategies for relapsed or refractory disease. The portfolio also extends to CAR T-cell therapy and other immune-based approaches in aggressive lymphoid cancers.

  • Diffuse large B-cell lymphoma (DLBCL)
  • Primary mediastinal large B-cell lymphoma (PMBCL)
  • Follicular lymphoma grade 3B
  • High-grade B-cell lymphoma (HGBL)

Investigations in this area also address treatment resistance and response assessment in relapsed/refractory lymphoma.

About Specializations

Universitaet Muenster runs clinical trials in conditions such as Acute kidney injury, Diffuse large B-cell lymphoma, Follicular lymphoma, High-grade B-cell lymphoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

14 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:MALIC ACID
  • Sponsor:Universitaet Muenster
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:Universitaet Muenster
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Gd2Il18Cart
  • Sponsor:Universitaet Muenster
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Universitaet Muenster
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ANGIOTENSIN II
  • Sponsor:Universitaet Muenster
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ttf-Ngr
  • Sponsor:Universitaet Muenster
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Universitaet Muenster
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Gadobutrol
  • Sponsor:Universitaet Muenster
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Aminolevulinic Acid Hydrochloride
  • Sponsor:Universitaet Muenster
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:Universitaet Muenster
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Axicabtagene Ciloleucel
  • Sponsor:Universitaet Muenster
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Universitaet Muenster

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.